CarSpers:sperm-specific ion channels; targets for male contraceptives

CarSpers:精子特异性离子通道;

基本信息

  • 批准号:
    7937160
  • 负责人:
  • 金额:
    $ 8.91万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-09-30 至 2011-09-29
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The fusion of sperm and egg lead to the combination of the father's and mother's genetic information to create a new individual. In humans, as in all mammals, sperm must reach the egg, penetrate its protective coat, fuse with the oocyte membrane, and deliver its genetic material. We have identified ion channels that are in spermatozoa, but not other tissues. CatSpers1-4 (Cation channel of Sperm) are 4 distinct genes present in all mammals, including humans, that encode 6 transmembrane-spanning ion channel protein subunits. These proteins form a sperm-specific, alkaline-activated, calcium-selective ion channel localized exclusively to the principal piece of the sperm tail. Male mice homozygous for null-mutations of any of the 4 CatSper genes are infertile but otherwise are completely normal. CatSper null sperm are unable to acquire hyperactivated motility and have reduced sperm endurance. Female mice lacking these genes appear completely normal, and have normal fertility. The CatSper protein spans the plasma membrane of the spermatozoan tail, and thus its extracellular surface is accessible to small molecules. The purpose of this proposal is to develop high throughput, and secondary verification screens, to identify drugs that block CatSper activity. A CatSper blocker should readily access binding sites on the external surface of sperm and thus prevent fertilization. Since CatSper is only expressed in mature sperm, a specific blocker should have no side effects on other cells and tissues, testicular function, or sperm development. PUBLIC RELEVANCE: We aim to develop an effective and safe male contraceptive. The drug will be targeted against a unique protein on the surface of mature sperm cells, called CatSper. CatSper is required for male fertility. Since the protein is only present on mature sperm, a drug inhibiting this molecule should have no effect on normal testicular or sperm development, and no effect on other organs within males or females.
描述(由申请人提供): 精子和卵子的融合导致父亲和母亲的遗传信息结合,创造出一个新的个体。人类和所有哺乳动物一样,精子必须到达卵子,穿透其保护层,与卵母细胞膜融合,并传递其遗传物质。我们已经确定了精子中的离子通道,而不是其他组织。CatSpers 1 -4(精子阳离子通道)是存在于包括人类在内的所有哺乳动物中的4个不同基因,编码6个跨膜离子通道蛋白亚基。这些蛋白质形成精子特异性的、碱激活的、钙选择性的离子通道,该离子通道仅定位于精子尾部的主要部分。4个CatSper基因中任何一个的空突变纯合的雄性小鼠是不育的,但在其他方面是完全正常的。CatSper无效精子不能获得超活化的运动力,并且具有降低的精子耐力。缺乏这些基因的雌性小鼠看起来完全正常,并且具有正常的生育能力。 CatSper蛋白跨越精子尾部的质膜,因此其细胞外表面可被小分子接近。该提案的目的是开发高通量和二级验证筛选,以鉴定阻断CatSper活性的药物。CatSper阻断剂应易于进入精子外表面的结合位点,从而防止受精。由于CatSper仅在成熟精子中表达,因此特定的阻断剂应该对其他细胞和组织,睾丸功能或精子发育没有副作用。 公众相关性:我们的目标是开发一种有效和安全的男性避孕药。该药物将针对成熟精子细胞表面的一种独特蛋白质,称为CatSper。CatSper是男性生育所必需的。由于这种蛋白质只存在于成熟的精子上,抑制这种分子的药物应该对正常的睾丸或精子发育没有影响,对男性或女性的其他器官也没有影响。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DAVID E. CLAPHAM其他文献

DAVID E. CLAPHAM的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DAVID E. CLAPHAM', 18)}}的其他基金

Canonical Transient Receptor Potential (TRPC) subfamily function in Hippocampus.
海马的典型瞬时受体电位 (TRPC) 亚家族功能。
  • 批准号:
    8394934
  • 财政年份:
    2010
  • 资助金额:
    $ 8.91万
  • 项目类别:
Canonical Transient Receptor Potential (TRPC) subfamily function in Hippocampus.
海马的典型瞬时受体电位 (TRPC) 亚家族功能。
  • 批准号:
    7864636
  • 财政年份:
    2010
  • 资助金额:
    $ 8.91万
  • 项目类别:
Canonical Transient Receptor Potential (TRPC) subfamily function in Hippocampus.
海马的典型瞬时受体电位 (TRPC) 亚家族功能。
  • 批准号:
    8590225
  • 财政年份:
    2010
  • 资助金额:
    $ 8.91万
  • 项目类别:
Canonical Transient Receptor Potential (TRPC) subfamily function in Hippocampus.
海马的典型瞬时受体电位 (TRPC) 亚家族功能。
  • 批准号:
    8204512
  • 财政年份:
    2010
  • 资助金额:
    $ 8.91万
  • 项目类别:
Canonical Transient Receptor Potential (TRPC) subfamily function in Hippocampus.
海马的典型瞬时受体电位 (TRPC) 亚家族功能。
  • 批准号:
    8044713
  • 财政年份:
    2010
  • 资助金额:
    $ 8.91万
  • 项目类别:
Novel CatSper3 and CatSper4 Ion Channel Genes in Sperm
精子中的新型 CatSper3 和 CatSper4 离子通道基因
  • 批准号:
    6703190
  • 财政年份:
    2004
  • 资助金额:
    $ 8.91万
  • 项目类别:
CarSpers:sperm-specific ion channels; targets for male contraceptives
CarSpers:精子特异性离子通道;
  • 批准号:
    7770820
  • 财政年份:
    2004
  • 资助金额:
    $ 8.91万
  • 项目类别:
Male contraception/CatSper1,2 sperm-specific ion channe*
男性避孕/CatSper1,2精子特异性离子通道*
  • 批准号:
    6848353
  • 财政年份:
    2004
  • 资助金额:
    $ 8.91万
  • 项目类别:
Novel CatSper3 and CatSper4 Ion Channel Genes in Sperm
精子中的新型 CatSper3 和 CatSper4 离子通道基因
  • 批准号:
    6819725
  • 财政年份:
    2004
  • 资助金额:
    $ 8.91万
  • 项目类别:
CarSpers:sperm-specific ion channels; targets for male contraceptives
CarSpers:精子特异性离子通道;
  • 批准号:
    8228095
  • 财政年份:
    2004
  • 资助金额:
    $ 8.91万
  • 项目类别:

相似海外基金

Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
  • 批准号:
    10591918
  • 财政年份:
    2023
  • 资助金额:
    $ 8.91万
  • 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
  • 批准号:
    23K15383
  • 财政年份:
    2023
  • 资助金额:
    $ 8.91万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
  • 批准号:
    23H03556
  • 财政年份:
    2023
  • 资助金额:
    $ 8.91万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
  • 批准号:
    23K17212
  • 财政年份:
    2023
  • 资助金额:
    $ 8.91万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
  • 批准号:
    22H03519
  • 财政年份:
    2022
  • 资助金额:
    $ 8.91万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
  • 批准号:
    563657-2021
  • 财政年份:
    2022
  • 资助金额:
    $ 8.91万
  • 项目类别:
    Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10521849
  • 财政年份:
    2022
  • 资助金额:
    $ 8.91万
  • 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10671022
  • 财政年份:
    2022
  • 资助金额:
    $ 8.91万
  • 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
  • 批准号:
    10670918
  • 财政年份:
    2022
  • 资助金额:
    $ 8.91万
  • 项目类别:
Downsides of downhill: The adverse effects of head vibration associated with downhill mountain biking on visuomotor and cognitive function
速降的缺点:与速降山地自行车相关的头部振动对视觉运动和认知功能的不利影响
  • 批准号:
    2706416
  • 财政年份:
    2022
  • 资助金额:
    $ 8.91万
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了